Press review following the announcement by the ANSM of Méningiomes sur-risk with Lotéran and Lotényl on June 17, 2020

These announcements make it possible to reach the maximum of possible women (more than 3 million take or have taken these two drugs).
Lutéran and Lotényl are much given for endometriosis and menopause, patients must therefore reassess with their doctor the risk-risk of treatment, in accordance with the announcements of the ANSM which are

• If you are currently processed by nomestrol (lutenyl and generic) or chlormadinone acetate (luteran and generics), we invite you to consult your doctor to discuss your care;

• If you are over 35 years old and you are treated by nomigestrol (lutenyl and generic) acetate) or chlormadinone (luteran and generic) acetate for over 5 years, your doctor will be able to offer you a brain imagery (MRI);

•  If you are, or have been, treated by nomestrol (lutenyl and generic) acetate) or chlormadinone (luteran and generic) acetate and you have symptoms evocative of meningioma (frequent headaches, vision, language or hearing disorders, dizziness, memory disorders, etc.), consult your doctor who will prescribe a cerebral imaging (MRI);

• If you have questions, talk to your doctor.

Medscape: https://www.univadis.fr/viewarticle/lutenyl-r-luteran-r-un-sur-risque-de-meningiome-723170

France Bleu: https://www.francebleu.fr/infos/sante-sciences/sante-risque-de-meningiome-confirm

Ouest-France: https://www.ouest-france.fr/sante/risque-de-tumeurs-cerebrales-confirme-pour-des-medicaments-progestififies-6871884

France Info: https://www.francetvinfo.fr/sante/medicament/sante-sanises-pour-traiter-la-menopause-les-roubles-menstruelles-et-lendometriose-le-lutenyl-et-le-luteran-ravoie-un-sur-Risque-de-Tumeur_4019.html

RTL: https://www.rtl.fr/actu/bien-etre/menopause-et-endometriose-risque-de-tumeur-cerebrale-a-cause-deticaments-progestififies-7800612794

Marie Claire: https://www.marieclaire.fr/lutenyl-luteran-meningioma-tumor-merebrale-menopause-ndometriose.1351461.asp

Le Figaro: http://leparticulier.lefigaro.fr/article/endometriose-menopause-le-luteran-et-le-lutenyl-augmenttent-le-risque-d-avoir-unmeur-cerebrale/

Europe 1: https://www.europe1.fr/Emons/le-bon-conseil-de-jimmy/menopause-roubles-menstruelles-et-endometriose-le-lutenyl-et-le-luteran-remis-en-cause-3975719 (where it is said that you should not look for information on the Internet!)

La Voix du Nord: https://www.lavoixdunord.fr/766051/article/2020-06-17/menopause-endometriose-le-luteran-et-le-lutenyl-multiplent-le-risque-de-tumeur

Top health: https://www.topsante.com/medecine/gyneco/luteran-lutenyl-augmenttent-le-risque-de-meningiome-tumeur-du-ce-637351

Le Journal des Femmes: https://sante.journaldesfemmes.fr/sexo-Gyneco/2445822-Medicament-luteran-lutenyl-meningiomé-ceur-ceveau-femme-alerte-endometriose-menopause/

The risk of meningioma increases if you take luteran or lutenyl (attention surgery images) 

Press following the announcement by the ANSM of Méningiomes sur-risk with Lotéran and Lotényl on June 17, 2020

Find the other Amavea articles here